IRVINE, Calif.--(BUSINESS WIRE)--eGene Inc. (OTCBB:EGEI), developer of a revolutionary high-performance genetic analysis technology, today announced that it plans to launch a complete solution for fast and low-cost bird flu screening by entering into a distribution agreement with Veredus Labs, Singapore for AIV-H5N1 PCR Kit Using eGene’s HDA-GT12 System.
